Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Flexbar 3.0 - SIMD and multicore parallelization.

Roehr JT, Dieterich C, Reinert K.

Bioinformatics. 2017 Sep 15;33(18):2941-2942. doi: 10.1093/bioinformatics/btx330.

PMID:
28541403
2.

Family-based association analyses of imputed genotypes reveal genome-wide significant association of Alzheimer's disease with OSBPL6, PTPRG, and PDCL3.

Herold C, Hooli BV, Mullin K, Liu T, Roehr JT, Mattheisen M, Parrado AR, Bertram L, Lange C, Tanzi RE.

Mol Psychiatry. 2016 Nov;21(11):1608-1612. doi: 10.1038/mp.2015.218. Epub 2016 Feb 2.

3.

A population genomic scan in Chorthippus grasshoppers unveils previously unknown phenotypic divergence.

Berdan EL, Mazzoni CJ, Waurick I, Roehr JT, Mayer F.

Mol Ecol. 2015 Aug;24(15):3918-30. doi: 10.1111/mec.13276. Epub 2015 Jul 17.

PMID:
26081018
4.

No association between CTNNBL1 and episodic memory performance.

Liu T, Li SC, Papenberg G, Schröder J, Roehr JT, Nietfeld W, Lindenberger U, Bertram L.

Transl Psychiatry. 2014 Sep 30;4:e454. doi: 10.1038/tp.2014.93.

5.

The rare TREM2 R47H variant exerts only a modest effect on Alzheimer disease risk.

Hooli BV, Parrado AR, Mullin K, Yip WK, Liu T, Roehr JT, Qiao D, Jessen F, Peters O, Becker T, Ramirez A, Lange C, Bertram L, Tanzi RE.

Neurology. 2014 Oct 7;83(15):1353-8. doi: 10.1212/WNL.0000000000000855. Epub 2014 Sep 3.

6.

Distinguishing true from false positives in genomic studies: p values.

Broer L, Lill CM, Schuur M, Amin N, Roehr JT, Bertram L, Ioannidis JP, van Duijn CM.

Eur J Epidemiol. 2013 Feb;28(2):131-8. doi: 10.1007/s10654-012-9755-x. Epub 2013 Feb 1.

PMID:
23371043
7.

Design and synthesis of D₁ agonist/D₂ antagonist for treatment of schizophrenia.

Giovanni A, Roehr J, Dwyer S, Neuenschwander K, Scotese A, Moorcroft ND, Davis L, Gao Z.

Bioorg Med Chem Lett. 2013 Mar 1;23(5):1498-501. doi: 10.1016/j.bmcl.2012.12.046. Epub 2012 Dec 21.

PMID:
23333208
8.

Closing the case of APOE in multiple sclerosis: no association with disease risk in over 29 000 subjects.

Lill CM, Liu T, Schjeide BM, Roehr JT, Akkad DA, Damotte V, Alcina A, Ortiz MA, Arroyo R, Lopez de Lapuente A, Blaschke P, Winkelmann A, Gerdes LA, Luessi F, Fernadez O, Izquierdo G, Antigüedad A, Hoffjan S, Cournu-Rebeix I, Gromöller S, Faber H, Liebsch M, Meissner E, Chanvillard C, Touze E, Pico F, Corcia P; ANZgene Consortium,{dagger}, Dörner T, Steinhagen-Thiessen E, Baeckman L, Heekeren HR, Li SC, Lindenberger U, Chan A, Hartung HP, Aktas O, Lohse P, Kümpfel T, Kubisch C, Epplen JT, Zettl UK, Fontaine B, Vandenbroeck K, Matesanz F, Urcelay E, Bertram L, Zipp F.

J Med Genet. 2012 Sep;49(9):558-62. doi: 10.1136/jmedgenet-2012-101175. Erratum in: J Med Genet. 2012 Oct;49(10):668.

PMID:
22972946
9.

Role of common and rare APP DNA sequence variants in Alzheimer disease.

Hooli BV, Mohapatra G, Mattheisen M, Parrado AR, Roehr JT, Shen Y, Gusella JF, Moir R, Saunders AJ, Lange C, Tanzi RE, Bertram L.

Neurology. 2012 Apr 17;78(16):1250-7. doi: 10.1212/WNL.0b013e3182515972. Epub 2012 Apr 4.

10.

Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database.

Lill CM, Roehr JT, McQueen MB, Kavvoura FK, Bagade S, Schjeide BM, Schjeide LM, Meissner E, Zauft U, Allen NC, Liu T, Schilling M, Anderson KJ, Beecham G, Berg D, Biernacka JM, Brice A, DeStefano AL, Do CB, Eriksson N, Factor SA, Farrer MJ, Foroud T, Gasser T, Hamza T, Hardy JA, Heutink P, Hill-Burns EM, Klein C, Latourelle JC, Maraganore DM, Martin ER, Martinez M, Myers RH, Nalls MA, Pankratz N, Payami H, Satake W, Scott WK, Sharma M, Singleton AB, Stefansson K, Toda T, Tung JY, Vance J, Wood NW, Zabetian CP; 23andMe Genetic Epidemiology of Parkinson's Disease Consortium; International Parkinson's Disease Genomics Consortium; Parkinson's Disease GWAS Consortium; Wellcome Trust Case Control Consortium 2), Young P, Tanzi RE, Khoury MJ, Zipp F, Lehrach H, Ioannidis JP, Bertram L.

PLoS Genet. 2012;8(3):e1002548. doi: 10.1371/journal.pgen.1002548. Epub 2012 Mar 15.

11.

FLEXBAR-Flexible Barcode and Adapter Processing for Next-Generation Sequencing Platforms.

Dodt M, Roehr JT, Ahmed R, Dieterich C.

Biology (Basel). 2012 Dec 14;1(3):895-905. doi: 10.3390/biology1030895.

12.

Comprehensive field synopsis and systematic meta-analyses of genetic association studies in cutaneous melanoma.

Chatzinasiou F, Lill CM, Kypreou K, Stefanaki I, Nicolaou V, Spyrou G, Evangelou E, Roehr JT, Kodela E, Katsambas A, Tsao H, Ioannidis JP, Bertram L, Stratigos AJ.

J Natl Cancer Inst. 2011 Aug 17;103(16):1227-35. doi: 10.1093/jnci/djr219. Epub 2011 Jun 21. Review.

13.

Cysteine 27 variant of the delta-opioid receptor affects amyloid precursor protein processing through altered endocytic trafficking.

Sarajärvi T, Tuusa JT, Haapasalo A, Lackman JJ, Sormunen R, Helisalmi S, Roehr JT, Parrado AR, Mäkinen P, Bertram L, Soininen H, Tanzi RE, Petäjä-Repo UE, Hiltunen M.

Mol Cell Biol. 2011 Jun;31(11):2326-40. doi: 10.1128/MCB.05015-11. Epub 2011 Apr 4.

14.

Impact of intensive nutritional education with carbohydrate counting on diabetes control in type 2 diabetic patients.

Zipp C, Roehr JT, Weiss LB, Filipetto F.

Patient Prefer Adherence. 2010 Dec 30;5:7-12. doi: 10.2147/PPA.S13907.

15.

Correspondence to Sand et Al. "Critical reappraisal of a catechol-o-methyltransferase transversion variant in schizophrenia".

Lill CM, Schjeide BM, Roehr JT, Zauft U, Allen NC, Zipp F, McQueen MB, Kavvoura FK, Ioannidis JP, Khoury MJ, Tanzi RE, Bertram L.

Biol Psychiatry. 2010 Apr 1;67(7):e45-8. doi: 10.1016/j.biopsych.2010.02.003. No abstract available.

PMID:
20303423
17.
18.

A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs.

Kongsamut S, Kang J, Chen XL, Roehr J, Rampe D.

Eur J Pharmacol. 2002 Aug 16;450(1):37-41.

PMID:
12176106
19.

Interaction of clozapine and other antipsychotic drugs with human alpha 1-adrenergic receptor subtypes.

Brooks KM, Cai J, Sandrasagra A, Roehr JE, Errazo R, Vargas HM.

Proc West Pharmacol Soc. 1999;42:67-9. No abstract available.

PMID:
10697693
20.

Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease.

Smith CP, Bores GM, Petko W, Li M, Selk DE, Rush DK, Camacho F, Winslow JT, Fishkin R, Cunningham DM, Brooks KM, Roehr J, Hartman HB, Davis L, Vargas HM.

J Pharmacol Exp Ther. 1997 Feb;280(2):710-20.

PMID:
9023283
21.

Iloperidone binding to human and rat dopamine and 5-HT receptors.

Kongsamut S, Roehr JE, Cai J, Hartman HB, Weissensee P, Kerman LL, Tang L, Sandrasagra A.

Eur J Pharmacol. 1996 Dec 19;317(2-3):417-23.

PMID:
8997630
22.

Structure-activity relationships of a series of novel (piperazinylbutyl)thiazolidinone antipsychotic agents related to 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2,5,5- trimethyl-4-thiazolidinone maleate.

Hrib NJ, Jurcak JG, Bregna DE, Burgher KL, Hartman HB, Kafka S, Kerman LL, Kongsamut S, Roehr JE, Szewczak MR, Woods-Kettelberger AT, Corbett R.

J Med Chem. 1996 Sep 27;39(20):4044-57.

PMID:
8831770
23.

Ex vivo studies with iloperidone (HP 873), a potential atypical antipsychotic with dopamine D2/5-hydroxytryptamine2 receptor antagonist activity.

Szczepanik AM, Brougham LR, Roehr JE, Conway PG, Ellis DB, Wilmot CA.

J Pharmacol Exp Ther. 1996 Aug;278(2):913-20.

PMID:
8768747
24.

Serotonergic activity of HP 184: does spontaneous release have a role?

Smith CP, Woods-Kettelberger AT, Corbett R, Chesson SM, Bores GM, Petko WW, Roehr JE, Kongsamut S.

Neurochem Res. 1996 May;21(5):575-83.

PMID:
8726966
25.

Besipirdine (HP 749) reduces schedule-induced polydipsia in rats.

Woods-Kettelberger AT, Smith CP, Corbett R, Szewczak MR, Roehr JE, Bores GM, Klein JT, Kongsamut S.

Brain Res Bull. 1996;41(2):125-30.

PMID:
8879677
26.

Changes in paroxetine binding in the cerebral cortex of polydipsic rats.

Roehr J, Woods A, Corbett R, Kongsamut S.

Eur J Pharmacol. 1995 May 4;278(1):75-8.

PMID:
7664815
27.

Benzisoxazole- and benzisothiazole-3-carboxamides as potential atypical antipsychotic agents.

Hrib NJ, Jurcak JG, Burgher KL, Conway PG, Hartman HB, Kerman LL, Roehr JE, Woods AT.

J Med Chem. 1994 Jul 22;37(15):2308-14.

PMID:
7914536
28.

3-[4-[1-(6-Fluorobenzo[b]thiophen-3-yl)-4-piperazinyl]butyl]- 2,5,5-trimethyl-4-thiazolidinone: a new atypical antipsychotic agent for the treatment of schizophrenia.

Hrib NJ, Jurcak JG, Bregna DE, Dunn RW, Geyer HM 3rd, Hartman HB, Roehr JE, Rogers KL, Rush DK, Szczepanik AM, et al.

J Med Chem. 1992 Jul 10;35(14):2712-5. No abstract available.

PMID:
1353116
29.

[On the standardization of column chromatography determination of certain aluminum oxides].

Böhme H, Bohn HJ, Roehr J.

Mitt Dtsch Pharm Ges Pharm Ges DDR. 1966 Mar;36(3):282-6. German. No abstract available.

PMID:
5952675
30.

[The new Goethe pharmacy in Jena].

ROEHR J.

Pharm Prax. 1961;6:92-4. German. No abstract available.

PMID:
14493255
31.

[The new Goethe Apothecary in Jena].

ROEHR J.

Pharm Prax. 1961;6:92-4. German. No abstract available.

PMID:
13742680

Supplemental Content

Support Center